The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District
- PMID: 26255258
- DOI: 10.1007/s00384-015-2352-1
The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District
Abstract
Background: High rates of advanced colorectal cancer (CRC) are still diagnosed in the right side of the colon. This study aimed to investigate whether screening programs increase CRC detection and whether tumor location is associated with survival outcome.
Methods: Patients affected by CRC, aged from 50 to 69 years and operated on from 2005 to 2009 were reviewed. Other than patient-, disease-, and treatment-related factors, detection mode and tumor location were recorded. Overall (OS) and disease-free survival (DFS) were investigated, using univariate and multivariate analyses.
Results: Mean age of 386 patients included was 62.0 years, 59 % were males. CRC was detected by screening in 17 % of cases, and diagnosis was made from symptoms in 67 % and emergency surgery for 16 %. Screen-detected CRCs were located in the left colon (59 %), then in rectum (25 %) and in proximal colon (16 %) (p = 0.02). Most of CRC patients urgently operated on had cancer located in proximal colon (45 %), then in the left colon (36 %) and in rectum (18 %) (p = 0.001). Right-sided CRC demonstrated higher pTNM stage (p = 0.001), adequate harvest count nodes (p = 0.0001), metastatic nodes (p = 0.02), and poor differentiation grading (p = 0.0001). With multivariate analysis, poor differentiation grade was independently associated with both worse OS (HR 3.6, p = 0.05) and worse DFS (HR 8.1, p = 0.0001), while distant recurrence was associated with worse OS (HR 20.1, p = 0.0001).
Conclusion: Low rates of right-sided CRC are diagnosed following screening program. Proximal CRC demonstrates aggressive behavior without impact on outcome. These findings prompt concern about population awareness for CRC screening.
Keywords: Colorectal cancer; Detection mode of cancer; Disease-free survival; Immunochemical fecal screening; Overall survival; Right-side tumor location.
Similar articles
-
Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study.Ann Intern Med. 2018 Nov 6;169(9):602-609. doi: 10.7326/M18-0855. Epub 2018 Oct 2. Ann Intern Med. 2018. PMID: 30285055
-
The detection of interval colorectal cancers following screening by fecal immunochemical test may predict worse outcomes and prompt ethical concerns: a 6-year population-based cohort study in a full district.Eur J Cancer Prev. 2019 Jan;28(1):17-26. doi: 10.1097/CEJ.0000000000000416. Eur J Cancer Prev. 2019. PMID: 29111981
-
Colorectal cancer liver metastases - a population-based study on incidence, management and survival.BMC Cancer. 2018 Jan 15;18(1):78. doi: 10.1186/s12885-017-3925-x. BMC Cancer. 2018. PMID: 29334918 Free PMC article.
-
Screening of colorectal cancer: present and future.Expert Rev Anticancer Ther. 2017 Dec;17(12):1131-1146. doi: 10.1080/14737140.2017.1392243. Epub 2017 Oct 26. Expert Rev Anticancer Ther. 2017. PMID: 29022408 Review.
-
Assessment of peritoneal elastic laminal invasion improves survival stratification of pT3 and pT4a colorectal cancer: a meta-analysis.J Clin Pathol. 2019 Nov;72(11):736-740. doi: 10.1136/jclinpath-2019-206056. Epub 2019 Aug 30. J Clin Pathol. 2019. PMID: 31471468 Review.
Cited by
-
The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients.Evid Based Complement Alternat Med. 2022 Sep 23;2022:4162354. doi: 10.1155/2022/4162354. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Dec 6;2023:9864685. doi: 10.1155/2023/9864685. PMID: 36193123 Free PMC article. Retracted.
-
Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004-2015.Cancer. 2019 Nov 1;125(21):3828-3835. doi: 10.1002/cncr.32347. Epub 2019 Jul 22. Cancer. 2019. PMID: 31328273 Free PMC article.
-
Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta-analysis.J Gene Med. 2019 Sep;21(9):e3114. doi: 10.1002/jgm.3114. Epub 2019 Aug 6. J Gene Med. 2019. PMID: 31330573 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical